Cargando…

A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model

PURPOSE: Currently >50% of high-risk neuroblastoma (NB) patients, despite intensive therapy and initial partial or complete response, develop recurrent NB due to the persistence of minimal residual disease (MRD) that is resistant to conventional antitumor drugs. Indeed, their low therapeutic inde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orienti, Isabella, Nguyen, Ferro, Guan, Peng, Kolla, Venkatadri, Calonghi, Natalia, Farruggia, Giovanna, Chorny, Michael, Brodeur, Garrett M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930389/ https://www.ncbi.nlm.nih.gov/pubmed/31908416 http://dx.doi.org/10.2147/DDDT.S221909

Ejemplares similares

Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti, Isabella, et al.
Publicado: (2020)

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
por: Orienti, Isabella, et al.
Publicado: (2020)

Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance
por: Alferiev, Ivan S., et al.
Publicado: (2022)

Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
por: Alferiev, Ivan S., et al.
Publicado: (2022)

Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model
por: Durante, Sandra, et al.
Publicado: (2014)

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma
por: Higashi, Mayumi, et al.
Publicado: (2015)

Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
por: Potenza, Rosa Luisa, et al.
Publicado: (2022)

Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
por: Naraparaju, Koumudi, et al.
Publicado: (2016)

Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
por: Lodeserto, Pietro, et al.
Publicado: (2022)

Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
por: Galassi, Lucrezia, et al.
Publicado: (2023)

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma
por: Cuperus, Roos, et al.
Publicado: (2009)

Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer Cells
por: Marcondes, Mariah C., et al.
Publicado: (2015)

Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma
por: Raguénez, Gilda, et al.
Publicado: (2009)

Nanomicellar Extraction of Polyphenols—Methodology and Applications Review
por: Śliwa, Paweł, et al.
Publicado: (2021)

CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
por: Fujita, Tomoyuki, et al.
Publicado: (2008)

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
por: Orienti, Isabella, et al.
Publicado: (2019)

Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer
por: Tan, Bee-Jen, et al.
Publicado: (2012)

Polymeric worm-like nanomicellar system for accelerated wound healing
por: Singh, Aarti, et al.
Publicado: (2020)

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
por: Orienti, Isabella, et al.
Publicado: (2019)

Sodium Ascorbate induces apoptosis in neuroblastoma cell lines by interfering with iron uptake
por: Carosio, Roberta, et al.
Publicado: (2007)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

Fenretinide: A Novel Treatment for Endometrial Cancer
por: Mittal, Navdha, et al.
Publicado: (2014)

Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells
por: Yang, Yaoli Pu, et al.
Publicado: (2016)

Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis
por: Helmy, Hebatullah Samy, et al.
Publicado: (2017)

Binary Polymeric Surfactant Mixtures for the Development of Novel Loteprednol Etabonate Nanomicellar Eyedrops
por: Tampucci, Silvia, et al.
Publicado: (2023)

Antitumor effect of lenalidomide in malignant glioma cell lines
por: Hanashima, Yuya, et al.
Publicado: (2020)

Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
por: Brack, Eva, et al.
Publicado: (2021)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
por: Zuccari, Guendalina, et al.
Publicado: (2023)

A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
por: Li, Zuojun, et al.
Publicado: (2018)

Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System
por: Alshamrani, Meshal, et al.
Publicado: (2022)

Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma
por: Swift, Lucy, et al.
Publicado: (2019)

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2023)

Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy
por: Dal Monte, Massimo, et al.
Publicado: (2020)

Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer
por: Nicoud, Melisa B., et al.
Publicado: (2023)

Fenretinide Causes Emphysema, Which Is Prevented by Sphingosine 1-Phoshate
por: Yasuo, Masanori, et al.
Publicado: (2013)

Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts
por: Sette, Giovanni, et al.
Publicado: (2013)

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
por: Otáhal, Pavel, et al.
Publicado: (2015)

Combination of Nanomicellar Technology and In Situ Gelling Polymer as Ocular Drug Delivery System (ODDS) for Cyclosporine-A
por: Terreni, Eleonora, et al.
Publicado: (2021)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells
por: Ruvolo, Vivian R., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n7u1b3fr9akd2mpv4592cn5nv4